Shortcast: Early treatment of neonatal diabetes with oral glibenclamide in extreme prematurity

Professor Michel Polak reports success using a specialist preparation of oral glibenclamide in the management of neonatal diabetes in an extreme preterm infant subsequently found to have a KCNJ11 gene variant. Early treatment of neonatal diabetes with oral glibenclamide in an extremely preterm infant Alfonso Galderisi, et al https://doi.org/10.1002/jmd2.12358